Standout Papers
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update (2023)
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 (2014)
Immediate Impact
5 by Nobel laureates 27 from Science/Nature 85 standout
Citing Papers
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Neoadjuvant checkpoint blockade for cancer immunotherapy
2020 StandoutScience
Works of Thomas J. Saphner being referenced
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update
2023 Standout
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
2014 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas J. Saphner | 1273 | 389 | 514 | 424 | 30 | 1.8k | |
| K. Panageas | 596 | 319 | 219 | 257 | 30 | 1.7k | |
| Federica Cuppone | 1117 | 589 | 380 | 149 | 50 | 1.5k | |
| Leyre Zubiri | 1239 | 422 | 282 | 323 | 56 | 1.9k | |
| James D. Reimann | 954 | 796 | 342 | 336 | 16 | 3.0k | |
| Roberta Camisa | 867 | 289 | 286 | 361 | 45 | 1.5k | |
| Frank A. Scappaticci | 1382 | 842 | 466 | 115 | 38 | 2.8k | |
| Beverly C. Handy | 983 | 426 | 661 | 109 | 47 | 1.9k | |
| Amy P. Sing | 1332 | 420 | 735 | 159 | 32 | 1.9k | |
| Robert S. Lavey | 718 | 490 | 364 | 138 | 52 | 2.4k | |
| Changping Wu | 1224 | 496 | 581 | 601 | 57 | 2.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...